SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-005659
Filing Date
2004-12-15
Accepted
2004-12-15 13:46:42
Documents
3
Period of Report
2004-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC b52793aie8vk.htm 8-K 14185
2 EX-10.1 FORM OF NON-STATUTORY STOCK OPTION CERTIFICATE b52793aiexv10w1.htm EX-10.1 13792
3 EX-10.2 2005 CASH COMPENSATION b52793aiexv10w2.htm EX-10.2 3999
  Complete submission text file 0000950135-04-005659.txt   33918
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 041204185
SIC: 2836 Biological Products, (No Diagnostic Substances)